The number of diabetics has been growing rapidly around the world and one third of them suffer from diabetic retinopathy, the most common cause of vision loss in working-age adults.
Diabetic retinopathy is treatable, if detected early. However, due to the limited number of ophthalmologists and eye screening services, majority of diabetics globally do not have access to regular screenings.
Effective eye screening prevents diabetes-related blindness and reduces overall health care costs.
We develop innovative and affordable solutions to enable eye screening for all patients worldwide.